Stamou, Maria I.
Chiu, Crystal J.
Jadhav, Shreya V.
Salnikov, Kathryn B.
Plummer, Lacey
Seminara, Stephanie B.
Balasubramanian, Ravikumar
Funding for this research was provided by:
NICHD (F32 HD108873)
National Institute of Child Health and Human Development (P50 HD104224, R01 HD096324)
FDA (R01 FD007843)
National Institute of Dental and Craniofacial Research (R01 DE031452)
Article History
Received: 16 December 2024
Accepted: 24 May 2025
First Online: 11 June 2025
Declarations
:
: The analysis of rare variant carriers and non-carrier controls was reviewed and approved by the Massachusetts General Brigham (MGB) Institutional Review Board (IRB Protocol 2009P002349). All participants provided written informed consent. Participants were recruited from the Mass General Brigham Biobank (MGBB), which has been reviewed and approved by the MGB IRB (Protocol 2009P002312). A variant association analysis with secondary use of clinical/research data under the MGH IRB Protocol 2020P000762, which has been reviewed and approved by the Massachusetts General Brigham Institutional Review Board, was also conducted.
: The authors declare no competing interests.